Scientists headed by a team at the University of British Columbia (UBC) have developed a new approach to drug design that can deliver therapeutics directly to a specific part of the gastrointestinal ...

Among the most recently approved drugs for weight management, glucagon-like peptide 1 (GLP-1) agonists have garnered considerable attention; however, the effects of these drugs on the gastrointestinal ...

Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital An institutional review board–approved study was ...

A rise in popularity in glucagon-like peptide 1 receptor agonists such as Ozempic and Wegovy is causing concern in the medical community over potential side effects for various physician specialties, ...

Sebela Pharmaceuticals, a pharma company that focuses on GI health, has entered an exclusive partnership to license GI medication tegoprazan in the U.S. and Canada. The medication works as an acid ...

Identify and compare mechanisms of action, safety, tolerability, and efficacy profiles of emerging therapies for common gastrointestinal (GI) disorders Recognize the roles of emerging therapies for ...

What Is a GI Cocktail? A gastrointestinal (GI) cocktail is a mixture of medications used to treat indigestion (dyspepsia), as well as symptoms of gastrointestinal problems such as chest and belly pain ...

The designation is supported by data from the 12-week, randomized, double-blind phase 2 FILLMORE trial. The Food and Drug Administration (FDA) has granted Orphan Drug designation to AMT-101 for the ...

When people swallow a pill, they expect the medicine to quickly reach the source of their pain or illness, but how well medications can be absorbed in the gastrointestinal tract is variable.

A patient with severe neck pain was prescribed a fentanyl patch for 30 days along with a muscle relaxer and a nonsteroidal anti-inflammatory drug (NSAID). She first developed constipation and then ...